Below is a detailed analysis of the quarterly data for Lactose (India) Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
For Sales, as of Mar 2025, the value is 27.77 Cr.. The value appears to be declining and may need further review. It has decreased from 28.72 Cr. (Dec 2024) to 27.77 Cr., marking a decrease of 0.95 Cr..
For Expenses, as of Mar 2025, the value is 24.36 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 25.75 Cr. (Dec 2024) to 24.36 Cr., marking a decrease of 1.39 Cr..
For Operating Profit, as of Mar 2025, the value is 3.41 Cr.. The value appears strong and on an upward trend. It has increased from 2.97 Cr. (Dec 2024) to 3.41 Cr., marking an increase of 0.44 Cr..
For OPM %, as of Mar 2025, the value is 12.28%. The value appears strong and on an upward trend. It has increased from 10.34% (Dec 2024) to 12.28%, marking an increase of 1.94%.
For Other Income, as of Mar 2025, the value is 0.37 Cr.. The value appears to be declining and may need further review. It has decreased from 0.56 Cr. (Dec 2024) to 0.37 Cr., marking a decrease of 0.19 Cr..
For Interest, as of Mar 2025, the value is 1.84 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.64 Cr. (Dec 2024) to 1.84 Cr., marking an increase of 0.20 Cr..
For Depreciation, as of Mar 2025, the value is 1.39 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.35 Cr. (Dec 2024) to 1.39 Cr., marking an increase of 0.04 Cr..
For Profit before tax, as of Mar 2025, the value is 0.55 Cr.. The value appears strong and on an upward trend. It has increased from 0.54 Cr. (Dec 2024) to 0.55 Cr., marking an increase of 0.01 Cr..
For Tax %, as of Mar 2025, the value is -18.18%. The value appears to be improving (decreasing) as expected. It has decreased from 59.26% (Dec 2024) to -18.18%, marking a decrease of 77.44%.
For Net Profit, as of Mar 2025, the value is 0.64 Cr.. The value appears strong and on an upward trend. It has increased from 0.22 Cr. (Dec 2024) to 0.64 Cr., marking an increase of 0.42 Cr..
For EPS in Rs, as of Mar 2025, the value is 0.45. The value appears strong and on an upward trend. It has increased from 0.16 (Dec 2024) to 0.45, marking an increase of 0.29.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
×
Quarterly Chart
Profit & Loss - Annual Report
Last Updated: Unknown
Metric
Mar 2013
Mar 2014
Mar 2015
Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
TTM
Sales
46
22
24
34
36
31
41
40
35
46
66
114
118
Expenses
43
21
19
24
24
25
31
31
29
34
54
95
98
Operating Profit
3
1
5
10
11
6
10
9
6
12
11
19
20
OPM %
6%
5%
22%
30%
32%
18%
24%
23%
18%
27%
17%
17%
17%
Other Income
1
2
0
1
1
1
0
0
0
1
1
1
1
Interest
1
1
3
4
4
5
5
6
5
5
6
5
5
Depreciation
2
2
2
3
3
4
4
4
4
5
5
5
6
Profit before tax
1
0
1
4
4
-3
1
0
-3
3
1
10
10
Tax %
30%
60%
42%
28%
36%
-52%
33%
30%
-24%
23%
18%
30%
Net Profit
1
0
0
3
3
-1
1
0
-2
2
1
7
7
EPS in Rs
1.28
0.04
0.59
3.17
2.87
-1.32
0.71
0.07
-2.17
1.95
0.96
5.39
5.48
Dividend Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
×
Profit & Loss Yearly Chart
YoY Net Profit Growth
Year
2013-2014
2016-2017
2017-2018
2018-2019
2019-2020
2021-2022
2022-2023
2023-2024
YoY Net Profit Growth (%)
-100.00%
0.00%
-133.33%
200.00%
-100.00%
200.00%
-50.00%
600.00%
Change in YoY Net Profit Growth (%)
0.00%
100.00%
-133.33%
333.33%
-300.00%
300.00%
-250.00%
650.00%
Lactose (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2013-2014 to 2023-2024.
Growth
Compounded Sales Growth
10 Years:
17%
5 Years:
24%
3 Years:
36%
TTM:
2%
Compounded Profit Growth
10 Years:
26%
5 Years:
136%
3 Years:
29%
TTM:
-24%
Stock Price CAGR
10 Years:
14%
5 Years:
39%
3 Years:
15%
1 Year:
-47%
Return on Equity
10 Years:
5%
5 Years:
6%
3 Years:
10%
Last Year:
10%
Last Updated: Unknown
No data available for the Balance Sheet data table.
Reserves and Borrowings Chart
Cash Flow
Month
Month
Mar 2014
Mar 2015
Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Cash from Operating Activity +
7
13
1
8
0
5
7
2
8
8
9
-0
Cash from Investing Activity +
-21
-23
3
-5
-2
-2
-3
-6
-1
-1
-2
-16
Cash from Financing Activity +
13
10
-5
-3
4
-5
-4
5
-8
-8
-6
19
Net Cash Flow
-1
-1
-0
-0
3
-2
1
1
-0
-1
1
3
Free Cash Flow Chart
Financial Efficiency Indicators
Month
Mar 2014
Mar 2015
Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Debtor Days
125
83
96
91
63
62
64
67
90
69
49
68
Inventory Days
69
129
344
440
456
384
471
587
343
344
119
171
Days Payable
308
273
340
559
330
242
202
153
195
275
59
74
Cash Conversion Cycle
-114
-61
100
-27
188
204
333
501
238
138
109
165
Working Capital Days
-20
-61
-33
-23
18
43
76
125
100
88
73
120
ROCE %
-3%
8%
13%
15%
4%
9%
8%
3%
10%
9%
18%
13%
Financial Efficiency Indicators Chart
Share Holding Pattern
Month
Jun 2022
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Promoters
53.79%
53.79%
53.79%
53.79%
53.79%
53.77%
53.66%
53.65%
53.65%
53.65%
53.65%
53.65%
DIIs
0.62%
0.62%
0.62%
0.62%
0.62%
0.62%
0.62%
0.62%
0.62%
0.62%
0.62%
0.62%
Public
45.59%
45.59%
45.59%
45.59%
45.59%
45.62%
45.73%
45.72%
45.74%
45.73%
45.73%
45.74%
No. of Shareholders
15,777
15,943
15,940
15,902
15,898
15,950
16,088
16,245
16,630
16,998
17,115
17,082
Shareholding Pattern Chart
No. of Shareholders
This stock is not held by any mutual fund.
ROCE / ROE Trend
EPS Trend
Key Financial Ratios
Month
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
FaceValue
10.00
10.00
10.00
10.00
10.00
Basic EPS (Rs.)
4.10
5.39
0.96
2.10
-2.40
Diluted EPS (Rs.)
4.06
5.39
0.96
2.10
-2.40
Cash EPS (Rs.)
8.38
9.54
4.68
5.57
1.64
Book Value[Excl.RevalReserv]/Share (Rs.)
46.66
37.41
32.22
31.20
30.68
Book Value[Incl.RevalReserv]/Share (Rs.)
46.66
37.41
32.22
31.20
30.68
Revenue From Operations / Share (Rs.)
92.46
90.47
52.26
36.49
30.57
PBDIT / Share (Rs.)
14.63
15.98
9.61
10.20
5.71
PBIT / Share (Rs.)
10.34
11.84
5.89
6.58
1.90
PBT / Share (Rs.)
5.50
7.68
1.16
2.52
-2.86
Net Profit / Share (Rs.)
4.10
5.39
0.96
1.95
-2.17
PBDIT Margin (%)
15.81
17.66
18.38
27.95
18.69
PBIT Margin (%)
11.18
13.08
11.26
18.02
6.22
PBT Margin (%)
5.94
8.48
2.22
6.89
-9.35
Net Profit Margin (%)
4.43
5.96
1.83
5.33
-7.08
Return on Networth / Equity (%)
8.78
14.41
2.97
6.23
-7.06
Return on Capital Employeed (%)
14.70
19.78
9.85
10.99
2.83
Return On Assets (%)
3.86
6.73
1.18
2.71
-2.80
Long Term Debt / Equity (X)
0.44
0.51
0.81
0.87
1.12
Total Debt / Equity (X)
0.95
0.80
0.95
1.04
1.20
Asset Turnover Ratio (%)
0.99
1.12
0.68
0.51
0.40
Current Ratio (X)
1.28
1.40
1.41
1.53
1.69
Quick Ratio (X)
0.73
0.73
0.55
1.05
0.97
Inventory Turnover Ratio (X)
2.93
2.47
2.37
0.72
0.53
Interest Coverage Ratio (X)
3.02
3.84
2.03
2.51
1.20
Interest Coverage Ratio (Post Tax) (X)
1.85
2.30
1.20
1.48
0.54
Enterprise Value (Cr.)
162.92
211.83
93.28
114.35
69.83
EV / Net Operating Revenue (X)
1.40
1.86
1.42
2.49
2.00
EV / EBITDA (X)
8.85
10.53
7.71
8.91
10.68
MarketCap / Net Operating Revenue (X)
0.95
1.54
0.84
1.64
0.87
Price / BV (X)
1.90
3.73
1.37
1.92
0.87
Price / Net Operating Revenue (X)
0.95
1.54
0.84
1.64
0.87
EarningsYield
0.04
0.03
0.02
0.03
-0.08
After reviewing the key financial ratios for Lactose (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:
For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 25, the value is 4.10. This value is below the healthy minimum of 5. It has decreased from 5.39 (Mar 24) to 4.10, marking a decrease of 1.29.
For Diluted EPS (Rs.), as of Mar 25, the value is 4.06. This value is below the healthy minimum of 5. It has decreased from 5.39 (Mar 24) to 4.06, marking a decrease of 1.33.
For Cash EPS (Rs.), as of Mar 25, the value is 8.38. This value is within the healthy range. It has decreased from 9.54 (Mar 24) to 8.38, marking a decrease of 1.16.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 46.66. It has increased from 37.41 (Mar 24) to 46.66, marking an increase of 9.25.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 46.66. It has increased from 37.41 (Mar 24) to 46.66, marking an increase of 9.25.
For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 92.46. It has increased from 90.47 (Mar 24) to 92.46, marking an increase of 1.99.
For PBDIT / Share (Rs.), as of Mar 25, the value is 14.63. This value is within the healthy range. It has decreased from 15.98 (Mar 24) to 14.63, marking a decrease of 1.35.
For PBIT / Share (Rs.), as of Mar 25, the value is 10.34. This value is within the healthy range. It has decreased from 11.84 (Mar 24) to 10.34, marking a decrease of 1.50.
For PBT / Share (Rs.), as of Mar 25, the value is 5.50. This value is within the healthy range. It has decreased from 7.68 (Mar 24) to 5.50, marking a decrease of 2.18.
For Net Profit / Share (Rs.), as of Mar 25, the value is 4.10. This value is within the healthy range. It has decreased from 5.39 (Mar 24) to 4.10, marking a decrease of 1.29.
For PBDIT Margin (%), as of Mar 25, the value is 15.81. This value is within the healthy range. It has decreased from 17.66 (Mar 24) to 15.81, marking a decrease of 1.85.
For PBIT Margin (%), as of Mar 25, the value is 11.18. This value is within the healthy range. It has decreased from 13.08 (Mar 24) to 11.18, marking a decrease of 1.90.
For PBT Margin (%), as of Mar 25, the value is 5.94. This value is below the healthy minimum of 10. It has decreased from 8.48 (Mar 24) to 5.94, marking a decrease of 2.54.
For Net Profit Margin (%), as of Mar 25, the value is 4.43. This value is below the healthy minimum of 5. It has decreased from 5.96 (Mar 24) to 4.43, marking a decrease of 1.53.
For Return on Networth / Equity (%), as of Mar 25, the value is 8.78. This value is below the healthy minimum of 15. It has decreased from 14.41 (Mar 24) to 8.78, marking a decrease of 5.63.
For Return on Capital Employeed (%), as of Mar 25, the value is 14.70. This value is within the healthy range. It has decreased from 19.78 (Mar 24) to 14.70, marking a decrease of 5.08.
For Return On Assets (%), as of Mar 25, the value is 3.86. This value is below the healthy minimum of 5. It has decreased from 6.73 (Mar 24) to 3.86, marking a decrease of 2.87.
For Long Term Debt / Equity (X), as of Mar 25, the value is 0.44. This value is within the healthy range. It has decreased from 0.51 (Mar 24) to 0.44, marking a decrease of 0.07.
For Total Debt / Equity (X), as of Mar 25, the value is 0.95. This value is within the healthy range. It has increased from 0.80 (Mar 24) to 0.95, marking an increase of 0.15.
For Asset Turnover Ratio (%), as of Mar 25, the value is 0.99. It has decreased from 1.12 (Mar 24) to 0.99, marking a decrease of 0.13.
For Current Ratio (X), as of Mar 25, the value is 1.28. This value is below the healthy minimum of 1.5. It has decreased from 1.40 (Mar 24) to 1.28, marking a decrease of 0.12.
For Quick Ratio (X), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.73.
For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.93. This value is below the healthy minimum of 4. It has increased from 2.47 (Mar 24) to 2.93, marking an increase of 0.46.
For Interest Coverage Ratio (X), as of Mar 25, the value is 3.02. This value is within the healthy range. It has decreased from 3.84 (Mar 24) to 3.02, marking a decrease of 0.82.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.85. This value is below the healthy minimum of 3. It has decreased from 2.30 (Mar 24) to 1.85, marking a decrease of 0.45.
For Enterprise Value (Cr.), as of Mar 25, the value is 162.92. It has decreased from 211.83 (Mar 24) to 162.92, marking a decrease of 48.91.
For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.40. This value is within the healthy range. It has decreased from 1.86 (Mar 24) to 1.40, marking a decrease of 0.46.
For EV / EBITDA (X), as of Mar 25, the value is 8.85. This value is within the healthy range. It has decreased from 10.53 (Mar 24) to 8.85, marking a decrease of 1.68.
For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.95. This value is below the healthy minimum of 1. It has decreased from 1.54 (Mar 24) to 0.95, marking a decrease of 0.59.
For Price / BV (X), as of Mar 25, the value is 1.90. This value is within the healthy range. It has decreased from 3.73 (Mar 24) to 1.90, marking a decrease of 1.83.
For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.95. This value is below the healthy minimum of 1. It has decreased from 1.54 (Mar 24) to 0.95, marking a decrease of 0.59.
For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.04, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
×
Profitability Ratios (%)
Liquidity Ratios
Liquidity Ratios (%)
Interest Coverage Ratios (%)
Valuation Ratios
Fair Value
Fair Value of Lactose (India) Ltd as of June 23, 2025 is: 90.57
Calculation basis:
Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.
As of June 23, 2025, Lactose (India) Ltd is Overvalued by 9.43% compared to the current share price 100.00
Intrinsic Value of Lactose (India) Ltd as of June 23, 2025 is: 139.44
Calculation basis:
Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.
This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.
As of June 23, 2025, Lactose (India) Ltd is Undervalued by 39.44% compared to the current share price 100.00
Last 5 Year EPS CAGR: 53.96%
*Investments are subject to market risks
Strength and Weakness
Unable to fetch valid data for stock valuation.
Stock Analysis
Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Lactose (India) Ltd:
Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
ROE%: 8.78% (Industry Average ROE: 15.19%)
ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
Stock P/E: 27.3 (Industry average Stock P/E: 93.79)
Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
Total Debt / Equity: 0.95
Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions. Stock Rating:
About the Company - Qualitative Analysis
Lactose (India) Ltd. is a Public Limited Listed company incorporated on 11/03/1991 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L15201GJ1991PLC015186 and registration number is 015186. Currently Company is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company's Total Operating Revenue is Rs. 116.40 Cr. and Equity Capital is Rs. 12.59 Cr. for the Year ended 31/03/2025.
INDUSTRY
ADDRESS
CONTACT
Pharmaceuticals
Survey No.5,6,7A, Village Poicha (Rania), Vadodra District Gujarat 391780
FAQ: Stock data is invalid or not in the correct format.
Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Lactose (India) Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
